Parvez Mantry

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

Rohit Loomba, Eric Lawitz, Parvez Mantry et al. · Hepatology · 2017 · 553 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

An Interferon-free Antiviral Regimen for HCV after Liver Transplantation

Paul Y. Kwo, Parvez Mantry, Eoin Coakley et al. · New England Journal of Medicine · 2014 · 402 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease

Paul J. Pockros, K. Rajender Reddy, Parvez Mantry et al. · Gastroenterology · 2016 · 278 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17